ClinicalTrials.gov
ClinicalTrials.gov Menu

BKM120 in Cancers With PIK3CA Activating Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01501604
Recruitment Status : Withdrawn (The study has been closed due to lack of accrual)
First Posted : December 29, 2011
Last Update Posted : September 17, 2015
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Jeffrey Engelman, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2013
  Actual Study Completion Date : August 2013